Axial Spondyloarthritis Treatment Advancements: Where Do Janus Kinase Inhibitors Fit In?
Description
Join our expert panel as they discuss the role of Janus kinase (JAK) inhibitors in the treatment of axial spondyloarthritis (axSpA).
Credit available for this activity expires: 4/24/25
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000707?ecd=bdc_podcast_libsyn_mscpedu
Did you know agitation is a treatable entity among patients with Alzheimer’s disease? Learn about potential causes and treatments for agitation.
Credit available for this activity expires: 10/29/25
Earn Credit / Learning Objectives & Disclosures:...
Published 10/29/24
Top tips for informed conversations with patients and their families around this new class of drugs for Alzheimer’s disease (AD).
Credit available for this activity expires: 10/28/25
Earn Credit / Learning Objectives & Disclosures: ...
Published 10/29/24